Analystreport

BridgeBio Pharma, Inc. (NASDAQ: BBIO) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00.

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report